CXCL12 and its receptor CXCR4 are known as key regulators of highly migratory/invasive phenotype of prostate cancer and their expression is associated with metastatic disease and poor survival [39,40,41]
GLP-1 medications can cause gastrointestinal symptoms, and MS patients on certain DMTs may already experience nausea or appetite changesoverlapping side effects require careful monitoring to distinguish medication effects from disease activity
Because some states or jurisdictions do not allow the exclusion or the limitation of liability for consequential or incidental damages, in such states or jurisdictions, our liability shall be limited to the maximum extent permitted by law
Theyre hoping to see cost savings, Moore said
Bogliun G, Marzorati L, Cavaletti G, Frattola L